. Author manuscript; available in PMC: 2015 Aug 1.

Published in final edited form as: Bone Marrow Transplant. 2014 Nov 17;50(2):197–203. doi: 10.1038/bmt.2014.259

Table 3.

Three-year adjusted probabilities.

Outcomes	MUD	MMUD	UCB	UCB vs MUD	UCB vs MMUD	MMUD vs MUD
	N=1173	N=274	N=140	p-value	p-value	p-value
	% (95% confidence interval)
Non relapse mortality	35 (32-38)	44 (39-50)	37 (28-46)	0.63	0.19	0.004
Relapse	33 (30-36)	25 (20-30)	30 (22-38)	0.48	0.27	0.003
Progression-free survival	33 (30-36)	30 (25-35)	31 (23-39)	0.72	0.81	0.35
Overall survival	43 (40-46)	37 (32-43)	41 (33-50)	0.77	0.45	0.073

Abbreviations: UCB umbilical cord blood, MMUD mismatched unrelated donor, MUD matched unrelated donor, Adjusted probabilities of progression-free survival, overall survival, relapse and non-relapse mortality for the 3 donor groups were based on a stratified Cox regression model. Karnofsky performance score, lymphoma subset, Graft versus host disease prophylaxis and disease status violated the proportionality assumption, and therefore, all the models were stratified on these variables.